← Eichor
Condition: Uncomplicated Infections Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Uncomplicated Infections

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparison of Uncomplicated Candidemia Therapy Duration in Children
NA · 22 location(s) · Arkansas Children's Hospital Research Institute · NCT05763251Oral Antibiotics Alone in Children Aged 4 Weeks to 2 Months With a Urinary Tract Infection
Phase N/A · 4 location(s) · Rigshospitalet, Denmark · NCT05819229Rapid Point-of-care Bacteriuria and Microbial Susceptibility for Women With Suspected Uncomplicated Urinary Tract Infect
Phase N/A · 2 location(s) · Wuerzburg University Hospital · NCT06625268A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Phase 2 · 17 location(s) · Locus Biosciences · NCT05488340Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria
Phase 2 · 1 location(s) · Victoria Biomedical Research Institute · NCT07559370Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women
Phase 3 · 13 location(s) · TCM Biotech International Corp. · NCT07184827500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea Infection
Phase 3 · 1 location(s) · National Taiwan University Hospital · NCT07710118Safety of Antimalarials in the FIRst trimEster
Phase 3 · 3 location(s) · Liverpool School of Tropical Medicine · NCT06962319Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
Phase N/A · 1 location(s) · Antonios Likourezos · NCT05227937Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Fal
Phase 2 · 12 location(s) · Novartis Pharmaceuticals · NCT05750628A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy
Phase 3 · 1 location(s) · Ruijin Hospital · NCT07229547Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia
Phase 3 · 12 location(s) · Clinical Research Centre, Malaysia · NCT06336824Time to Clearance of Chlamydia Trachomatis and Neisseria Gonorrhoeae RNA After Treatment: a Prospective Cohort Study
NA · 1 location(s) · University Hospital, Strasbourg, France · NCT06216964Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
Phase 4 · 1 location(s) · Medical College of Wisconsin · NCT06494072
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.